当前位置：首页 > 文献互助 > 互助详情

Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells复制

用户NybQ738PJkRU 1个月前 66 10 已完结

1. 系统已在2025-07-12 16:13:11对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1021/jacs.5c02801复制

文献链接:复制

其他信息:

上一篇：Room-temperature synthesis of blue-emissive zero-dimensional cesium indium halide quantum dots for temperature-stable down-conversion white light-emitting diodes with a half-lifetime of 186 h

下一篇：The Landscape of Medical AI in China

互助时间线

2025-07-05 16:14:19 [完结求助]

楼主确认了小小星星应助的文件是正确的, 求助状态变成 已完结

2025-07-05 16:13:11 [上传文件]

小小星星上传了文件(pdf 4.03 MB), 求助状态变成 待确认

2025-07-05 16:12:41 [发起求助]

最新发布的求助

Visitation patterns reveal service access disparities for ageing populations in the USA 9小时前
Cobalt-catalysed alkene hydronitration enabled by anomeric nitroamide 10小时前
Stability assessment of Polatuzumab vedotin and Brentuximab vedotin using different analytical techniques 11小时前
2024年度中国新药盘点 11小时前
2023年度中国新药盘点 11小时前
The immunology of asthma 13小时前
Breastfeeding After Hormone Receptor–Positive Breast Cancer: Results From the POSITIVE Trial 13小时前
Soft electronics based on particle engulfment printing 13小时前
ALD-Al2O3 passivation effects on surface characteristics of InAs/GaSb type-II superlattice infrared photodetectors 13小时前
Meta-analysis study on anesthetic sedation recovery and onset times in pediatric and elderly patients undergoing CT and MRI 13小时前
Research and perspective of heterogeneous catalytic oxidation by ozone in the removal of pollutants from industrial wastewater: A review 14小时前
使用不同分析技术评估 Polatuzumab vedotin 和 Brentuximab vedotin 的稳定性 14小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com